Literature DB >> 26278693

Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population.

Adam C Janot1, Dörte Huscher, McCall Walker, Harmonjot K Grewal, Mary Yu, Matthew R Lammi, Lesley Ann Saketkoo.   

Abstract

INTRODUCTION: Sarcoidosis is a multi-organ system granulomatous disease of unknown origin with an incidence of 1-40/100,000. Though pulmonary manifestations are predominant, ocular sarcoidosis (OS) affects 25-50% of patients with sarcoidosis and can lead to blindness.
METHODS: A retrospective, single-center chart review of sarcoidosis cases investigated variables associated with the development of OS. Inclusion criteria were biopsy-proven sarcoidosis, disease duration greater than 1 year, documented smoking status on chart review and documentation of sarcoid-related eye disease. Multivariate analysis identified independent risk factors for OS.
RESULTS: Of 269 charts reviewed, 109 patients met inclusion criteria. The OS group had a significantly higher proportion of smokers (71.4%) than without OS (42.0%, p=0.027) with no difference (p=0.61) in median number of pack years. Male sex was significantly higher in the OS group (57.1% versus 26.1%, p=0.009). Median duration of sarcoidosis was higher in the OS group (10 versus 4 years, p=0.031). Multivariate regression identified tobacco exposure (OR=5.25, p=0.007, 95% CI 1.58-17.41), male sex (OR=7.48, p=0.002, 95% CI 2.15-26.01), and age (OR=1.114, p=0.002, 95% CI 1.04-1.19) as concomitant risk factors for the development of OS.
CONCLUSION: To date, there are few dedicated investigations of risk factors for OS, especially smoking. This investigation identified male sex, age, and tobacco exposure as independent risk factors for OS. Though disease duration did not withstand regression analysis in this moderately sized group, age at chart review suggests screening for OS should not remit but rather intensify in aging patients with sarcoidosis.

Entities:  

Mesh:

Year:  2015        PMID: 26278693      PMCID: PMC4994533     

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  41 in total

Review 1.  Ocular involvement in sarcoidosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

2.  Cigarette smoking in 99 metropolitan areas--United States, 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-12-14       Impact factor: 17.586

3.  A case control etiologic study of sarcoidosis: environmental and occupational risk factors.

Authors:  Lee S Newman; Cecile S Rose; Eddy A Bresnitz; Milton D Rossman; Juliana Barnard; Margaret Frederick; Michael L Terrin; Steven E Weinberger; David R Moller; Geoffrey McLennan; Gary Hunninghake; Louis DePalo; Robert P Baughman; Michael C Iannuzzi; Marc A Judson; Genell L Knatterud; Bruce W Thompson; Alvin S Teirstein; Henry Yeager; Carol J Johns; David L Rabin; Benjamin A Rybicki; Reuben Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2004-09-03       Impact factor: 21.405

4.  Smoking inhibits the frequency of bronchovascular bundle thickening in sarcoidosis.

Authors:  Alicia K Gerke; Edwin van Beek; Gary W Hunninghake
Journal:  Acad Radiol       Date:  2011-05-06       Impact factor: 3.173

5.  Is tobacco smoking protective for sarcoidosis? A case-control study from North India.

Authors:  D Gupta; A D Singh; R Agarwal; A N Aggarwal; K Joshi; S K Jindal
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2010-07       Impact factor: 0.670

6.  Immunohistopathology of ocular sarcoidosis. Report of a case and discussion of immunopathogenesis.

Authors:  C C Chan; R P Wetzig; A G Palestine; T Kuwabara; R B Nusenblatt
Journal:  Arch Ophthalmol       Date:  1987-10

7.  Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1992-12

8.  Release of tumor necrosis factor-alpha from human alveolar macrophages is decreased in smokers.

Authors:  E Yamaguchi; A Itoh; K Furuya; H Miyamoto; S Abe; Y Kawakami
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

9.  Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease.

Authors:  D Valeyre; P Soler; C Clerici; J Pré; J P Battesti; R Georges; A J Hance
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

10.  Tobacco smoking-associated risk for tuberculosis: a case-control study.

Authors:  Harvir S Gambhir; Rajeev M Kaushik; Reshma Kaushik; Girish Sindhwani
Journal:  Int Health       Date:  2010-09       Impact factor: 2.473

View more
  7 in total

Review 1.  Ocular sarcoidosis: new diagnostic modalities and treatment.

Authors:  Sung J Yang; Sherveen Salek; James T Rosenbaum
Journal:  Curr Opin Pulm Med       Date:  2017-09       Impact factor: 3.155

Review 2.  How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants.

Authors:  Manuel Ramos-Casals; Belchin Kostov; Pilar Brito-Zerón; Antoni Sisó-Almirall; Robert P Baughman
Journal:  Lung       Date:  2019-06-12       Impact factor: 2.584

3.  A Gene-Environment Interaction Between Smoking and Gene polymorphisms Provides a High Risk of Two Subgroups of Sarcoidosis.

Authors:  Natalia V Rivera; Karina Patasova; Susanna Kullberg; Lina Marcela Diaz-Gallo; Tomoko Iseda; Camilla Bengtsson; Lars Alfredsson; Anders Eklund; Ingrid Kockum; Johan Grunewald; Leonid Padyukov
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

4.  Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan.

Authors:  Takeshi Hattori; Satoshi Konno; Noriharu Shijubo; Tetsuo Yamaguchi; Yukihiko Sugiyama; Sakae Honma; Naohiko Inase; Yoichi M Ito; Masaharu Nishimura
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

5.  Ocular Manifestations of Sarcoidosis in a South Florida Population.

Authors:  Diana Laura; Yonghoon Lee; Monika Farhangi; Oriana Salamo; Mehdi Mirsaeidi; Raquel Goldhardt; Anat Galor
Journal:  Clin Ophthalmol       Date:  2020-11-02

6.  Nasal mucociliary transportability of male and female smokers.

Authors:  Juliana Souza Uzeloto; Dionei Ramos; Ana Paula C F Freire; Diego G D Christofaro; Ercy Mara C Ramos
Journal:  Braz J Otorhinolaryngol       Date:  2017-04-08

7.  Associations between occupational and environmental exposures and organ involvement in sarcoidosis: a retrospective case-case analysis.

Authors:  Steven Ronsmans; Jolien De Ridder; Eline Vandebroek; Stephan Keirsbilck; Benoit Nemery; Peter H M Hoet; Steven Vanderschueren; Wim A Wuyts; Jonas Yserbyt
Journal:  Respir Res       Date:  2021-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.